M
-
DATABASE (2758)
-
ARTICLES (56)
Based in London, CPT Capital is the venture arm of private equity pioneer Jeremy Coller's private family office. Coller is the founder of Europe’s first private equity for secondaries in 1990. The British philanthropist has also established several business schools and the Jeremy Coller Foundation that aims to eliminate factory farming. In 2017, CPT Capital was founded to disrupt the food industry with investments in the alt-protein sector to create the “future of food and materials” like plant-based, recombinant and cell-cultured proteins.
Based in London, CPT Capital is the venture arm of private equity pioneer Jeremy Coller's private family office. Coller is the founder of Europe’s first private equity for secondaries in 1990. The British philanthropist has also established several business schools and the Jeremy Coller Foundation that aims to eliminate factory farming. In 2017, CPT Capital was founded to disrupt the food industry with investments in the alt-protein sector to create the “future of food and materials” like plant-based, recombinant and cell-cultured proteins.
Founded in 2016 by Gary Schefsky, New Luna Ventures focuses on sustainable investments in diverse sectors including agriculture, food tech, precision farming, materials, real estate, renewables, water technology, communications, SaaS, AI and robotics. Schefsky has worked in emerging startup sectors for over 25 years and as a family office fiduciary for more than 17 years. Based in San Francisco, the firm’s limited partners include family offices, institutional investors and individuals.
Founded in 2016 by Gary Schefsky, New Luna Ventures focuses on sustainable investments in diverse sectors including agriculture, food tech, precision farming, materials, real estate, renewables, water technology, communications, SaaS, AI and robotics. Schefsky has worked in emerging startup sectors for over 25 years and as a family office fiduciary for more than 17 years. Based in San Francisco, the firm’s limited partners include family offices, institutional investors and individuals.
Founded in September 2019 by Patrick Morris, Eat Beyond went public on the Canadian Securities Exchange in November 2020. The company’s shares are also traded on the Frankfurt Exchange in Germany and OTC Markets in the US. Morris had worked in capital markets for over 15 years and wanted to find a solution to help retail investors access the emerging markets of alt-proteins and other future food sectors.First of its kind in Canada, the Eat Beyond Global Investment Fund focuses on four key areas: meat, seafood, eggs, and dairy. It also participates in cell agriculture and other experimental projects. Current investments include foodtechs and alt-food source companies working on plant-based proteins, fermented proteins, cultured proteins, agriculture and consumer packaged goods.
Founded in September 2019 by Patrick Morris, Eat Beyond went public on the Canadian Securities Exchange in November 2020. The company’s shares are also traded on the Frankfurt Exchange in Germany and OTC Markets in the US. Morris had worked in capital markets for over 15 years and wanted to find a solution to help retail investors access the emerging markets of alt-proteins and other future food sectors.First of its kind in Canada, the Eat Beyond Global Investment Fund focuses on four key areas: meat, seafood, eggs, and dairy. It also participates in cell agriculture and other experimental projects. Current investments include foodtechs and alt-food source companies working on plant-based proteins, fermented proteins, cultured proteins, agriculture and consumer packaged goods.
Established in 1958, VERSO Capital is a boutique merchant banking and financial services firm based in Luxembourg. It also has offices in Geneva, Fribourg, Vaduz, Dubai, Singapore and BVI. VERSO specializes in sectors like education, food and renewables. Since 2011, the firm has invested over $700bn in venture capital in the global startup ecosystem. Funds worth over $245m were pumped into climatech, foodtech and biotech sectors since 2017. In February 2021, it merged with Swiss alternative asset manager ALDINI Capital that was also founded in 1958 and based in Switzerland and Liechtenstein. VERSO will leverage the expertise of ALDINI in hedge funds, private equity and real estate.
Established in 1958, VERSO Capital is a boutique merchant banking and financial services firm based in Luxembourg. It also has offices in Geneva, Fribourg, Vaduz, Dubai, Singapore and BVI. VERSO specializes in sectors like education, food and renewables. Since 2011, the firm has invested over $700bn in venture capital in the global startup ecosystem. Funds worth over $245m were pumped into climatech, foodtech and biotech sectors since 2017. In February 2021, it merged with Swiss alternative asset manager ALDINI Capital that was also founded in 1958 and based in Switzerland and Liechtenstein. VERSO will leverage the expertise of ALDINI in hedge funds, private equity and real estate.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2011, London-based Agronomics Limited’s principal investing interest is in environmentally-friendly alternatives to the traditional production of meat, wherever they may be located. There are currently 17 companies in its portfolio, all of them in the cellular-based or plant-based protein category and sustainable food production.Its most recent declared investments have been in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the December 2020 undisclosed pre-seed round of Chinese cellular foodtech CellX.
Founded in 2011, London-based Agronomics Limited’s principal investing interest is in environmentally-friendly alternatives to the traditional production of meat, wherever they may be located. There are currently 17 companies in its portfolio, all of them in the cellular-based or plant-based protein category and sustainable food production.Its most recent declared investments have been in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the December 2020 undisclosed pre-seed round of Chinese cellular foodtech CellX.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise). He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise). He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Berlin in 2016, Atlantic Food Labs’ mission is to support startups with the potential to feed 10bn people by 2050. It has supported 20 companies to date and its most recent investments include in the German healthy last-minute delivery service Gorillas’ $290m Series B round and in the €5.9m seed round of B2B German retail connection service Magaloop in March 2021.
Founded in Berlin in 2016, Atlantic Food Labs’ mission is to support startups with the potential to feed 10bn people by 2050. It has supported 20 companies to date and its most recent investments include in the German healthy last-minute delivery service Gorillas’ $290m Series B round and in the €5.9m seed round of B2B German retail connection service Magaloop in March 2021.
BACKED VC is primarily a seed-stage funder based in London and founded in 2015 that selects its investments based on the founding team rather than on market-based decisions. It typically invests from €0.5m to €2.5m per round and, to date, has invested in 45 startups with two exits so far. Its most recent investments include in the March 2021 £5m Series A round of British legal digitization platform Legl and in the February 2021 £2.7m seed round of UK-based cellular fat producer Hoxton Farms.
BACKED VC is primarily a seed-stage funder based in London and founded in 2015 that selects its investments based on the founding team rather than on market-based decisions. It typically invests from €0.5m to €2.5m per round and, to date, has invested in 45 startups with two exits so far. Its most recent investments include in the March 2021 £5m Series A round of British legal digitization platform Legl and in the February 2021 £2.7m seed round of UK-based cellular fat producer Hoxton Farms.
Founded in 2016, Paris-based Future Positive Capital invests in European startups in deep tech and biotechnology to solve major problems, with funding for only 20 portfolio startups. It has backed eight startups to date with its most recent investments being in the April 2021 undisclosed €5.2m funding round of French renewable energytech SWEETCH Energy and in the £7.9m Series A round of British ecosystem restoration technology Dendra Systems in September 2020.
Founded in 2016, Paris-based Future Positive Capital invests in European startups in deep tech and biotechnology to solve major problems, with funding for only 20 portfolio startups. It has backed eight startups to date with its most recent investments being in the April 2021 undisclosed €5.2m funding round of French renewable energytech SWEETCH Energy and in the £7.9m Series A round of British ecosystem restoration technology Dendra Systems in September 2020.
Charles Songhurst is a founding partner of hedge fund Katana Capital and also runs the Songhurst Group, which holds assets in a variety of private companies, besides being a prolific angel investor having invested in more than 500 companies to date across sectors and geographies. His most recent investments have included in the 2021 seed rounds of home-based eye medtech Quadrant Eye and in the $2m funding of Canadian small business logistics startup Tyltgo. Songhurst is a former general manager and former head of corporate strategy at Microsoft. He has a bachelor's in philosophy, politics and economics from Oxford University.
Charles Songhurst is a founding partner of hedge fund Katana Capital and also runs the Songhurst Group, which holds assets in a variety of private companies, besides being a prolific angel investor having invested in more than 500 companies to date across sectors and geographies. His most recent investments have included in the 2021 seed rounds of home-based eye medtech Quadrant Eye and in the $2m funding of Canadian small business logistics startup Tyltgo. Songhurst is a former general manager and former head of corporate strategy at Microsoft. He has a bachelor's in philosophy, politics and economics from Oxford University.
Infinited Fiber: Producing biofibers for fashion to move toward circular economy
Supported by H&M, Adidas and textile manufacturers, Infinited Fiber is helping the world’s second most polluting industry go greener by turning industrial waste into regenerated biomaterials
Cautiously opportunistic: How Indonesian VCs are riding out the Covid-19 crisis
Indonesian VCs on how they are doing deals during Covid-19, and their advice to startups, from how to cut costs to M&A
Autodrive Solutions: Making driverless vehicles safer with high-precision positioning tech
A Spanish university's research on sophisticated weapons detection technology is being used to prevent accidents in the mobility and transport sectors
Xampla: Making strong, low-cost biodegradable plastic from peas
Inspired by the strength of spider silk, the Cambridge University spinoff has produced a plant-based, completely compostable alternative to microplastics
Carlos Guerrero: The legal guardian of tech startups
The lawyer and investor dives deep in the Spanish startup ecosystem, supporting young tech companies with both financial and specialized legal support
Qlue on international expansion, privacy concerns in smart cities
Qlue's CEO Rama Raditya and CCO Maya Arvini on protecting individual privacy when handling citizens' data in smart cities, the lack of clarity in regulation of use of facial recognition technology in Indonesia
Gojek acquires Indonesian POS startup Moka, gains greater share of SME fintech market
Deal reportedly worth $120m will add Moka's network of over 30,000 merchants to Gojek's reach
This voice technology startup empowers both developers and machines
AISpeech shifted its business from education to IoT but has always remained focused on voice interaction between humans and machines
After a Covid-led boom in 2020, what next for China's K-12 edtech?
Unicorns Yuanfudao and Zuoyebang raised more than $6bn combined last year as demand for online learning continues to grow, but some smaller players are running out of cash
UPDATE: Indonesian mPOS startup Cashlez raises IDR 85bn from IPO in May
Cashlez is the first fintech company to list on the Indonesia Stock Exchange; will spend over 60% of proceeds to acquire payments company in toll road market
Medigo teams up with Indonesian Medical Association to launch primary care clinic network
Medigo aims to support healthcare operators with its clinic management SaaS, booking and medical records app for patients and more
TuSimple: Banking on autonomous trucking in the US
TuSimple aims to scale its Waymo-style driverless trucking network to disrupt the $4tn global truck freight market starting with the US, with mass production by 2024
Traveloka CTO Derianto Kusuma resigns
The co-founder cites a changing ecosystem and company direction for his decision, while hinting at a new venture
Indonesian angel investor network ANGIN launches agrifood incubator
Program targets ESG investment and builds on the strong potential of Indonesia’s agriculture sector, which kept growing despite the Covid-19 pandemic
A new unicorn rises as OVO's $1bn valuation confirmed
The Lippo Group subsidiary continues to grow in strength as it battles for market share with Gojek’s e-wallet and others
Sorry, we couldn’t find any matches for “M”.
POPULAR DATABASE
